{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:56:18Z","timestamp":1794434178039,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"am","delay-in-days":232,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020523","name":"United States Drug Enforcement Administration","doi-asserted-by":"publisher","award":["HHSF223201610079C"],"award-info":[{"award-number":["HHSF223201610079C"]}],"id":[{"id":"10.13039\/100020523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004909"],"award-info":[{"award-number":["UM1TR004909"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003107"],"award-info":[{"award-number":["UL1TR003107"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110562","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:20:51Z","timestamp":1749756051000},"page":"110562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-2400","authenticated-orcid":false,"given":"Brenda M.","family":"Gannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9703-1951","authenticated-orcid":false,"given":"Mary E.","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9132-8201","authenticated-orcid":false,"given":"Justin M.","family":"Pressley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1600-2894","authenticated-orcid":false,"given":"Hannah E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla J.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4868-8913","authenticated-orcid":false,"given":"Marina","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery H.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-1593","authenticated-orcid":false,"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt A","key":"10.1016\/j.neuropharm.2025.110562_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110562_bib2","first-page":"1584","article-title":"Hands-Free analytical urine testing technology validated for drug-facilitated crime investigations","volume":"36","author":"Avram","year":"2023","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110562_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcpt.13786","article-title":"Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis","volume":"131","author":"Axelsson","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110562_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF02361229","article-title":"Intake of ethanol, sodium chloride, sucrose, citric acid, and quinine hydrochloride solutions by mice: a genetic analysis","volume":"26","author":"Bachmanov","year":"1996","journal-title":"Behav. Genet."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1530-0277.1996.tb01630.x","article-title":"Ethanol consumption and taste preferences in C57BL\/6ByJ and 129\/J mice","volume":"20","author":"Bachmanov","year":"1996","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110562_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2021.1169","article-title":"Continued increases in overdose deaths related to synthetic opioids: implications for clinical practice","volume":"325","author":"Baldwin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2025.110562_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1901\/jeab.1973.20-119","article-title":"Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration","volume":"20","author":"Balster","year":"1973","journal-title":"J. Exp. Anal. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/ijms26020444","article-title":"The rise of fentanyl: molecular aspects and forensic investigations","volume":"26","author":"Barletta","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110562_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl","volume":"17","author":"Bird","year":"2023","journal-title":"J. Addiction Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110562_bib10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","article-title":"Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis","volume":"48","author":"Butelman","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0091-3057(89)90336-5","article-title":"Taste vs. CNS effects in voluntary oral opiate intake: studies with a novel device and technique","volume":"34","author":"Carlson","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110562_bib12","unstructured":"Centers for Disease Control and Prevention. Prescription Opioid Data | Opioid Overdose. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/drugoverdose\/data\/prescribing.html. Published December 21, 2018."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/00952990.2021.1891420","article-title":"A cross-sectional analysis of fentanyl analog exposures among living patients","volume":"47","author":"Chhabra","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib14","first-page":"R718","article-title":"Taste reactivity responses in rats: influence of sex and the estrous cycle","volume":"274","author":"Clarke","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110562_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13344","article-title":"Rapid appearance of negative emotion during oral fentanyl self-administration in male and female rats","volume":"28","author":"Coffey","year":"2023","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib15","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1542\/peds.2014-2878","article-title":"Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage","volume":"135","author":"Cole","year":"2015","journal-title":"Pediatrics"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2025.110562_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3959(00)00413-9","article-title":"Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats","volume":"91","author":"Colpaert","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110562_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110562_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2019.01.045","article-title":"Trends in fentanyl and fentanyl analogue-related overdose deaths - montgomery County, Ohio, 2015-2017","volume":"198","author":"Daniulaityte","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110562_bib20","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.119156","article-title":"Full opioid agonists and tramadol: pharmacological and clinical considerations","volume":"11","author":"Edinoff","year":"2021","journal-title":"Anesthesiol. Pain Med."},{"key":"10.1016\/j.neuropharm.2025.110562_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110562_bib22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0090-9556(25)07486-0","article-title":"Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4","volume":"24","author":"Feierman","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2025.110562_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0041-008X(64)90021-3","article-title":"A study of some of the pharmacological actions of fentanyl citrate","volume":"6","author":"Gardocki","year":"1964","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110562_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214406","article-title":"The genotoxicity of acrylfentanyl, ocfentanyl and furanylfentanyl raises the concern of long-term consequences","volume":"23","author":"Gasperini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51279-6","article-title":"Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients","volume":"9","author":"Geist","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.122.001267","article-title":"Attenuation of the positive-reinforcing effects of ultra-potent fentanyl analogs, along with those of fentanyl and heroin, during daily treatment with methocinnamox in rhesus monkeys","volume":"384","author":"Gerak","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110562_bib27","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/add.14614","article-title":"How the complex pharmacology of the fentanyls contributes to their lethality","volume":"114","author":"Gill","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/11531740-000000000-00000","article-title":"Formulations of fentanyl for the management of pain","volume":"70","author":"Grape","year":"2010","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2007.10.005","article-title":"Ethanol drinking in rodents: is free-choice drinking related to the reinforcing effects of ethanol?","volume":"42","author":"Green","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110562_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.drugalcdep.2018.05.034","article-title":"The effect of quinine in two bottle choice procedures in C57BL6 mice: opioid preference, somatic withdrawal, and pharmacokinetic outcomes","volume":"191","author":"Grim","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110562_bib31","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1007\/s00044-012-0390-6","article-title":"Synthesis and comparative bioefficacy of N-(1-phenethyl-4-piperidinyl)propionanilide (fentanyl) and its 1-substituted analogs in Swiss albino mice","volume":"22","author":"Gupta","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110562_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/15563650.2016.1139715","article-title":"Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project","volume":"54","author":"Helander","year":"2016","journal-title":"Clin. Toxicol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110562_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/15563650.2017.1303141","article-title":"Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project","volume":"55","author":"Helander","year":"2017","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110562_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-007-0039-1","article-title":"Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure\u2013analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues","volume":"26","author":"Higashikawa","year":"2008","journal-title":"Forensic Toxicol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.123.002032","article-title":"Comparison of the \u03bc-opioid receptor antagonists methocinnamox and naloxone to reverse and prevent the ventilatory depressant effects of fentanyl, carfentanil, 3-methylfentanyl, and heroin in male rats","volume":"391","author":"Hiranita","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110562_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"115","author":"Hursh","year":"2008","journal-title":"Psychol. Rev."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110562_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1021\/tx025674x","article-title":"Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analogues","volume":"16","author":"Hutzler","year":"2003","journal-title":"Chem. Res. Toxicol."},{"issue":"6408","key":"10.1016\/j.neuropharm.2025.110562_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1373\/clinchem.2017.281626","article-title":"The fentanyl epidemic and evolution of fentanyl analogs in the United States and the European union","volume":"65","author":"Jannetto","year":"2019","journal-title":"Clin. Chem."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2025.110562_bib40","article-title":"Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019","volume":"229","author":"Jiang","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110562_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/bph.15573","article-title":"The anomalous pharmacology of fentanyl","volume":"180","author":"Kelly","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1037\/1064-1297.9.3.251","article-title":"Effects of adolescent nicotine exposure on opioid consumption and neuroendocrine responses in adult male and female rats","volume":"9","author":"Klein","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1037\/1064-1297.5.2.99","article-title":"Sex differences in effects of predictable and unpredictable footshock on fentanyl self-administration in rats","volume":"5","author":"Klein","year":"1997","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110562_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu. Rev. Publ. Health"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3959(94)00106-O","article-title":"The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain","volume":"60","author":"Kupers","year":"1995","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110562_bib44","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00213-024-06641-6","article-title":"Reinforcing effects of fentanyl analogs found in illicit drug markets","volume":"241","author":"Maitland","year":"2024","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110562_bib45","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00213-021-05850-7","article-title":"Escalation and reinstatement of fentanyl self-administration in male and female rats","volume":"238","author":"Malone","year":"2021","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110562_bib46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2165\/00003088-198308050-00004","article-title":"Clinical pharmacokinetics of fentanyl and its newer derivatives","volume":"8","author":"Mather","year":"1983","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110562_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0009-9236(99)70008-1","article-title":"The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo","volume":"66","author":"Mirghani","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110562_bib48","unstructured":"Obeng S, Urquhart KR, Fukuda S, Pallares VLC, McMahon LR, Fantegrossi WE and Hiranita T (submitted) in vitro and in vivo pharmacological characterization of fentanyl analogs. Neuropharmacology, under review."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib70","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00213-020-05722-6","article-title":"Aversion-resistant fentanyl self-administration in mice","volume":"238","author":"Monroe","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110562_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s002130050618","article-title":"Effects of delivery rate and non-contingent infusions of cocaine on cocaine self-administration in rhesus monkeys","volume":"137","author":"Panlilio","year":"1998","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib50","doi-asserted-by":"crossref","DOI":"10.15761\/FSC.1000125","article-title":"Multi-laboratory validation of a \u03949-tetrahydrocannabinol LC-MS\/MS test kit designed for quantifying THC and marijuana metabolites in blood","volume":"3","author":"Patton","year":"2018","journal-title":"Forensic Sci. Criminol."},{"key":"10.1016\/j.neuropharm.2025.110562_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112799","article-title":"Hemoglobin adducts of acrylamide in human blood - what has been done and what is next?","volume":"161","author":"Pedersen","year":"2022","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110562_bib52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/dta.3663","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS\/MS) method including 25 novel synthetic opioids in hair and subsequent analysis of a Swiss opioid consumer cohort","volume":"16","author":"Polke","year":"2024","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2025.110562_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11419-018-0445-6","article-title":"Immunoassay-based detection of fentanyl analogs in forensic toxicology","volume":"37","author":"Schackmuth","year":"2019","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110562_bib54","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0091-3057(92)90382-P","article-title":"Effect of stress on oral morphine and fentanyl self-administration in rats","volume":"41","author":"Shaham","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110562_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF02253539","article-title":"Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on \"relapse\" to opioid drugs","volume":"111","author":"Shaham","year":"1993","journal-title":"Psychopharmacology"},{"issue":"6\u20137","key":"10.1016\/j.neuropharm.2025.110562_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10408440600851377","article-title":"Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects","volume":"36","author":"Shipp","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110562_bib58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annemergmed.2014.07.017","article-title":"The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl \"disguised\" as other opioids","volume":"64","author":"Stogner","year":"2014","journal-title":"Ann. Emerg. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib59","first-page":"167","article-title":"Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation","volume":"82","author":"Tateishi","year":"1996","journal-title":"Anesth. Analg."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110562_bib72","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0091-3057(99)00262-2","article-title":"Fentanyl self-administration in juvenile rats that were tolerant and dependent to fentanyl as infants","volume":"65","author":"Thornton","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110562_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841873","article-title":"Sex- and dose-dependent differences in the development of an addiction-like phenotype following extended-access fentanyl self-administration","volume":"13","author":"Towers","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/pharmrev.121.000361","article-title":"Sex\/gender differences in the time-course for the development of substance use disorder: a focus on the telescoping effect","volume":"75","author":"Towers","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110562_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173572","article-title":"Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression","volume":"226","author":"Varshneya","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110562_bib63","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archpsyc.1995.03950180042006","article-title":"Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain","volume":"52","author":"Volkow","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2025.110562_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2008.04.007","article-title":"Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration","volume":"587","author":"Wade","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib75","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1037\/h0028208","article-title":"Hormonal and developmental influences on rat saccharin preferences","volume":"69","author":"Wade","year":"1969","journal-title":"J. Comp. Physiol. Psychol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110562_bib64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0031-9384(69)90044-4","article-title":"Taste preferences of female rats: modification by neonatal hormones, food deprivation and prior experience","volume":"4","author":"Wade","year":"1970","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110562_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/h0028713","article-title":"Development of hormonal control over food intake and body weight in female rats","volume":"70","author":"Wade","year":"1970","journal-title":"J. Comp. Physiol. Psychol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110562_bib66","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1208\/s12248-017-0070-z","article-title":"In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl","volume":"19","author":"Watanabe","year":"2017","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110562_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00429186","article-title":"Test for oral and postingestional factors mediating differential acceptability of morphine, methamphetamine, and chlordiazepoxide drinking solutions","volume":"60","author":"Wolf","year":"1978","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110562_bib68","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jcph.469","article-title":"Pharmacokinetic interaction of intravenous fentanyl with ketoconazole","volume":"55","author":"Ziesenitz","year":"2015","journal-title":"J. Clin. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:23:05Z","timestamp":1779614585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":74,"alternative-id":["S0028390825002680"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110562","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110562"}}